Open AccessAllopurinol effects on residual renal function in end-stage renal disease patients undergoing peritoneal dialysis: Randomized controlled trial
Author(s) -
Firouzeh Moeinzadeh,
Elham Kabiri Naeini,
Mojgan Mortazavi
Publication year - 2019
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/jrpp.jrpp_18_72
Subject(s) - medicine , allopurinol , renal function , urology , uric acid , hyperuricemia , creatinine , randomized controlled trial , dialysis , end stage renal disease , peritoneal dialysis , surgery , hemodialysis
There is increasing evidence to show that hyperuricemia may have a pathogenic role in the progression of renal diseases. We performed a prospective, randomized, controlled trial to investigate the renal effects of allopurinol treatment in hyperuricemic patients with end-stage renal disease (ESRD) who undergo peritoneal dialysis.